Endo-beta-N-acetylglucosaminidase Inhibitors (IC50, Ki)

Structure ▲ ▼	Compound Name ▲ ▼	Standard Type ▲ ▼	Standard Values (in nM) ▲ ▼
	Nagstatin	IC50	1.83 [1]
	Nagstatin	Ki	0.93 [1]
	N-[[(1R,2S,3S,5S,7R,8S)-1,2,7-Trihydroxy-5-(hydroxymethyl)-2,3,5,6,7,8-hexahydro-1H-pyrrolizin-3-yl]methyl]acetamide	IC50	2.39 [1]
	N-[[(1R,2S,3S,5S,7R,8S)-1,2,7-Trihydroxy-5-(hydroxymethyl)-2,3,5,6,7,8-hexahydro-1H-pyrrolizin-3-yl]methyl]acetamide	Ki	1.25 [1]
	(2S,3S)-3-Hydroxybaikiain	IC50	750000.0 [1]
	Omeprazole	IC50	25000.0 [1]
	Lansoprazole	IC50	24380.0 [1]
	Rabeprazole	IC50	4470.0 [1]
	Dexlansoprazole	IC50	25000.0 [1]
	Tenatoprazole	IC50	20000.0 [1]
	(2S,3S,4S,5S,6R)-2-[[(2R,3S,4S,5S,6S)-6-[[(2R,3R,4S,5S,6S)-6-[[(2R,3R,4S,5S,6S)-6-[[(3As,5R,6S,7R,7aR)-7-hydroxy-5-(hydroxymethyl)-2-methyl-5,6,7,7a-tetrahydro-3aH-pyrano[3,2-d][1,3]thiazol-6-yl]oxy]-4-[(2S,3S,4S,5S,6R)-3-[(2S,3S,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5-dihydroxyoxan-2-yl]methoxy]-4-[(2S,3S,4S,5R,6R)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,5-dihydroxyoxan-2-yl]methoxy]-3,4,5-trihydroxyoxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol	IC50	420.0 [1]

Entire TableStructureCompound NameStandard TypeStandard Values (in nM)

Items per page: 510All1 - 10 of 11 ⟨⟩

---

---

References

This online tool may be cited as follows

MLA	"Quest Database™ Endo-beta-N-acetylglucosaminidase Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 21 Nov. 2024, https://www.aatbio.com/data-sets/endo-beta-n-acetylglucosaminidase-inhibitors-ic50-ki.
APA	AAT Bioquest, Inc. (2024, November 21). Quest Database™ Endo-beta-N-acetylglucosaminidase Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/endo-beta-n-acetylglucosaminidase-inhibitors-ic50-ki.
BibTeX	EndNote	RefMan